ATARA BIOTHERAPEUTICS, INC. Supplemental Unemployment Benefits, Severance Benefits
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Supplemental Unemployment Benefits, Severance Benefits of $800.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Compensation Related Costs
us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits · last filed 2026-08-12
- 2026-06-30: Supplemental Unemployment Benefits, Severance Benefits $800.00K.
- 2026-03-31: Supplemental Unemployment Benefits, Severance Benefits $100.00K.
- 2025-12-31: Supplemental Unemployment Benefits, Severance Benefits $900.00K.
- 2025-10-31: Supplemental Unemployment Benefits, Severance Benefits $1.20M.
| Period end | Supplemental Unemployment Benefits, Severance Benefits | Supplemental Unemployment Benefits, Severance Benefits as first filed |
|---|---|---|
| 2026-06-30 | $800.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $900.00K 10-Q · filed 2026-08-12 | |
| 2025-10-31 | $1.20M 10-K · filed 2026-03-16 | |
| 2025-05-31 | $1.40M 10-K · filed 2026-03-16 | |
| 2025-03-31 | $2.80M 10-K · filed 2026-03-16 | $2.70M 10-Q · filed 2025-05-15 |
| 2025-01-31 | $7.20M 10-K · filed 2026-03-16 | $7.10M 10-Q · filed 2025-05-15 |
| 2024-01-31 | $5.10M 10-Q · filed 2025-11-12 | $4.80M 10-Q · filed 2024-05-09 |
| 2024-01-08 | $5.10M 10-K · filed 2026-03-16 | |
| 2023-12-31 | $6.70M 10-K · filed 2024-03-28 | |
| 2023-11-30 | $6.70M 10-Q · filed 2025-11-12 | |
| 2023-11-01 | $6.70M 10-K · filed 2026-03-16 | |
| 2022-08-31 | $6.00M 10-K · filed 2023-02-08 | $6.30M 10-Q · filed 2022-11-08 |
| 2022-08-08 | $6.00M 10-K · filed 2026-03-16 | $6.30M 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |